Finasteride Treatment of Severe Nodulocystic Acne
Public ClinicalTrials.gov record NCT02502669. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study Evaluating the Efficacy and Safety of Once Weekly High Dose Oral Finasteride in the Treatment of Severe Nodulocystic Acne
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Double-blind, randomized, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of once weekly, high dose oral finasteride compared to placebo for the treatment of severe nodulocystic acne in male subjects.
Study identification
- NCT ID
- NCT02502669
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 106 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 35 Years
- Sex
- Male
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2015
- Primary completion
- Jun 5, 2017
- Completion
- Jun 5, 2017
- Last update posted
- Feb 14, 2019
2015 – 2017
United States locations
- U.S. sites
- 25
- U.S. states
- 15
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Omni Dermatology, Inc. | Phoenix | Arizona | 85018 | — |
| Burke Pharmaceutical Research | Hot Springs | Arkansas | 71913 | — |
| Dr. Ronald Moy | Beverly Hills | California | 90210 | — |
| Axis Clinical Trials | Los Angeles | California | 90036 | — |
| Orange County Research Center | Tustin | California | 92780 | — |
| Horizons Clinical Research Center, LLC. | Denver | Colorado | 80220 | — |
| MOORE Clinical Research, Inc. | Brandon | Florida | 33511 | — |
| Advanced Medcial Research Institiute | Miami Lakes | Florida | 33174 | — |
| Park Avenue Dermatology | Orange Park | Florida | 32073 | — |
| International Clinical Research | Sanford | Florida | 32771 | — |
| Lenus Research & Medical Group | Sweetwater | Florida | 33172 | — |
| Marietta Dermatology Clinical Research, Inc. | Marietta | Georgia | 30060 | — |
| MedaPhase, Inc. | Newnan | Georgia | 30263 | — |
| Northwest Clinical Trials | Boise | Idaho | 83704 | — |
| Glazer Dermatology | Buffalo Grove | Illinois | 60089 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Summit Dermatology | Oakbrook Terrace | Illinois | 60181 | — |
| Dawes Fretzin Clinical Research Group. LLC | Indianapolis | Indiana | 46256 | — |
| The Indiana Clinical Trials Center, PC | Plainfield | Indiana | 46168 | — |
| Hamzavi Dermatology | Fort Gratiot | Michigan | 48059 | — |
| MediSearch Clinical Trials | Saint Joseph | Missouri | 64506 | — |
| Greenwich Village Dermatology | New York | New York | 10012 | — |
| UHCMC Skin Study Center | Cleveland | Ohio | 44106 | — |
| Paddington Testing Co., Inc. | Philadelphia | Pennsylvania | 19103 | — |
| Invocare Clinical Research Center | West Columbia | South Carolina | 29169 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02502669, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 14, 2019 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02502669 live on ClinicalTrials.gov.